glp-1 colorectal cancer risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Ozempic, Wegovy might lower colon – glp-1 colorectal cancer death risk

Uninsured patients often discover that tax-advantaged savings accounts cover GLP-1 therapy, effectively reducing out-of-pocket costs beyond the base monthly price

Rybelsus is not suitable for everyone, and you shouldnt take it if: If youre scheduled for surgery requiring anaesthesia, make sure to inform your doctor that youre taking Rybelsus

A.C

Most common adverse reactions for Wegovy (semaglutide) The most common adverse reactions for Wegovy (incidence 5%) are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss

According to the American Gastroenterological Association (2021), PA should be viewed as a late-stage manifestation of autoimmune gastritis

Increased nausea, vomiting, early fullness even with small meals, bloating, and abdominal discomfort signal possible intolerance